Compare CORT & SSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CORT | SSD |
|---|---|---|
| Founded | 1998 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 8.2B |
| IPO Year | 2001 | 1996 |
| Metric | CORT | SSD |
|---|---|---|
| Price | $95.41 | $193.75 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 4 |
| Target Price | $96.50 | ★ $214.75 |
| AVG Volume (30 Days) | ★ 1.1M | 286.3K |
| Earning Date | 04-30-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 0.61% |
| EPS Growth | N/A | ★ 8.42 |
| EPS | N/A | ★ 2.13 |
| Revenue | $761,407,000.00 | ★ $2,332,808,000.00 |
| Revenue This Year | $26.08 | $3.82 |
| Revenue Next Year | $26.98 | $5.57 |
| P/E Ratio | ★ N/A | $88.85 |
| Revenue Growth | ★ 12.79 | 4.51 |
| 52 Week Low | $28.66 | $156.32 |
| 52 Week High | $97.05 | $213.49 |
| Indicator | CORT | SSD |
|---|---|---|
| Relative Strength Index (RSI) | 63.30 | 52.58 |
| Support Level | $76.41 | $162.84 |
| Resistance Level | N/A | $197.09 |
| Average True Range (ATR) | 4.17 | 4.64 |
| MACD | -0.36 | -0.36 |
| Stochastic Oscillator | 81.02 | 80.13 |
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.
Simpson Manufacturing Co Inc designs, manufactures, and markets systems and products to make buildings and structures safe and secure. It produces wood construction products, including connectors, truss plates, fastening systems, fasteners, and shearwalls, as well as concrete construction products such as adhesives, specialty chemicals, mechanical anchors, powder actuated tools, and fiber reinforcing materials. The company serves residential, industrial, commercial, and infrastructure construction, remodeling, and do-it-yourself markets, operating exclusively in the building products industry. It has three regional segments: North America, Europe, and Asia/Pacific. The majority of its revenue comes from wood products.